LANXESS expands Lewatit range

  • New Lewatit ion exchange resins and adsorbers for separation, purification, and chromatography of biomolecules
  • Specific solutions for the pharmaceutical and bioprocessing industries
  • Opening new market access
Cologne
Quality control of Lewatit ion exchange resins under the microscope
LANXESS
In order to achieve a high degree of reproducibility and thus quality consistency in Lewatit production, exact compliance with the reaction parameters is crucial. For this reason, the relevant process steps are largely automated. The quality control laboratory of LANXESS’s Liquid Purification Technologies business unit verifies the ion exchange and adsorber resins according their specification during production. Photo: LANXESS

Specialty chemicals company LANXESS has grouped together 16 new ion exchange resins and absorbents for the pharmaceutical and bioprocessing industries under its trusted umbrella brand Lewatit. They are used in various pharmaceutical and bioprocessing applications to separate and purify biomolecules. Applications of these end products range from food and animal feeds to active pharmaceutical ingredients (APIs) that are used in medicinal products.

“Typically, our products support the separation of biomolecules from complex biomass mixtures and play a key role in their further purification or stabilization,” explained Dr. Jenny Boettger, Technical Marketing Manager in the Liquid Purification Technologies (LPT) business unit at LANXESS. “As one of the leading manufacturers of ion exchange resins, we are hoping that this innovative product range will attract new customers from the pharmaceutical and bioprocessing industries and further strengthen our market position,” added the chemist.

New resins for downstream processes

The production of biomolecules derived from natural extracts and biological fermentation processes is strongly supported by a wide range of Lewatit ion exchange and adsorber resins. This resin technology opens up a variety of separation and purification options for all kinds of operation scales. The new types are specifically designed to be used in downstream processing for production of various biomolecules, including products from animal- and plant-sourced natural extracts. All resins are based on hydrophobic (polystyrene-divinylbenzene) or medium hydrophilic (polyacrylic) polymers. They were specifically developed to meet the high demands in industries such as biotechnology, pharmaceuticals, biopharmaceuticals, nutraceuticals, and food production in order to detoxify, convert, decolorize, or demineralize the respective molecules more easily.

Through ion exchange or adsorption processes, biomolecules such as peptides, antibiotics, vitamins, amino acids, and polysaccharides can be separated and purified more effectively. All these biomolecules are indispensable in today’s world. Antibiotics are essential for the treatment of bacterial infectious diseases. The intake of vitamins and numerous amino acids and proteins supports vital functions of the body. Diverse polysaccharides are found in part in everyday use. In the form of heparin and structure-like polysaccharides, for example, they are used to prevent venous thrombosis. In cosmetics, hyaluronic acid acts as a humectant due to its high water-binding capacity.

Outstanding features

Benefits of Lewatit include good chemical and mechanical bead stabilities, excellent kinetics and selectivity’s, high capacities, and good economics due to lean design and high performance. and come with a certificate and statement.

LANXESS’s biopharmaceutical-quality ion exchange resins and adsorbents are halal, kosher, non-GMO, and come with certificates and statements including information about allergens, heavy metals and food regulations.

Detailed information, including technical product data sheets and certificates, can be found online at https://lanxess.com/en/Products-and-Solutions/Brands/Lewatit.

Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

PRESS RELEASE
Modular plant for water purification usimg Lewatit TP 108 DW ion exchange resin. Operatot De Watergroep, Belgium

LANXESS’ ion exchange resin for mobile water treatment unit for PFAS removal

November 19, 2024
PRESS RELEASE
refrigeration lubricant, synthetic ester lubricant Everest ESR 220, HVAC (heating, ventilation and air conditioning) and refrigeration systems

LANXESS launches environmentally sustainable refrigeration lubricant Everest ESR 220

November 13, 2024
PRESS RELEASE
Since August 1, 2013, specialty chemicals Group LANXESS is steering its global business from the LANXESS Tower in Cologne.

LANXESS significantly increases earnings in the third quarter of 2024

November 07, 2024
PRESS RELEASE
LANXESS Headquarters in Cologne

LANXESS signs contract to sell Urethane Systems business to UBE Corporation

October 03, 2024
PRESS RELEASE
LANXESS corporate headquarters in Cologne

LANXESS signs new sustainable credit line for EUR 800 million

September 26, 2024